X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11039) 11039
Book Review (1731) 1731
Publication (649) 649
Book / eBook (26) 26
Book Chapter (26) 26
Conference Proceeding (11) 11
Magazine Article (10) 10
Dissertation (9) 9
Web Resource (8) 8
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10177) 10177
humans (9798) 9798
female (7309) 7309
middle aged (4961) 4961
oncology (4496) 4496
male (4444) 4444
aged (3910) 3910
adult (3728) 3728
peritoneal neoplasms - secondary (3204) 3204
cancer (3073) 3073
surgery (2912) 2912
peritoneal neoplasms - drug therapy (2780) 2780
chemotherapy (2465) 2465
peritoneal neoplasms - pathology (1922) 1922
peritoneal neoplasms - therapy (1921) 1921
combined modality therapy (1886) 1886
prognosis (1880) 1880
animals (1799) 1799
antineoplastic combined chemotherapy protocols - therapeutic use (1756) 1756
peritoneal neoplasms - surgery (1683) 1683
treatment outcome (1616) 1616
ovarian cancer (1420) 1420
neoplasm staging (1389) 1389
retrospective studies (1374) 1374
ovarian neoplasms - pathology (1305) 1305
ovarian neoplasms - drug therapy (1282) 1282
survival rate (1274) 1274
medicine & public health (1268) 1268
cytoreductive surgery (1233) 1233
peritoneal carcinomatosis (1225) 1225
carcinoma (1212) 1212
mice (1210) 1210
metastasis (1203) 1203
aged, 80 and over (1197) 1197
stomach neoplasms - pathology (1142) 1142
obstetrics & gynecology (1117) 1117
survival (1055) 1055
peritoneal neoplasms - mortality (1016) 1016
hyperthermia, induced (986) 986
follow-up studies (978) 978
care and treatment (952) 952
analysis (940) 940
tumors (905) 905
abridged index medicus (898) 898
peritoneal neoplasms - diagnosis (851) 851
antineoplastic agents - therapeutic use (841) 841
antineoplastic agents - administration & dosage (825) 825
infusions, parenteral (740) 740
health aspects (737) 737
cisplatin - administration & dosage (733) 733
cisplatin (728) 728
chemotherapy, adjuvant (716) 716
research (716) 716
surgical oncology (701) 701
survival analysis (691) 691
colorectal cancer (665) 665
disease-free survival (664) 664
colorectal neoplasms - pathology (663) 663
intraperitoneal chemotherapy (661) 661
hematology, oncology and palliative medicine (647) 647
stomach neoplasms - drug therapy (645) 645
liver neoplasms - secondary (640) 640
management (635) 635
carcinomatosis (630) 630
cell line, tumor (628) 628
tomography, x-ray computed (623) 623
therapy (610) 610
hyperthermic intraperitoneal chemotherapy (609) 609
gastroenterology & hepatology (594) 594
lymphatic metastasis (593) 593
colorectal-cancer (586) 586
peritoneum (560) 560
gastric cancer (555) 555
recurrence (554) 554
prospective studies (544) 544
injections, intraperitoneal (543) 543
paclitaxel (528) 528
ovarian neoplasms - surgery (523) 523
stomach neoplasms - surgery (519) 519
diagnosis (517) 517
risk factors (512) 512
mesothelioma (511) 511
time factors (510) 510
pathology (505) 505
mortality (503) 503
stomach cancer (501) 501
adolescent (500) 500
antineoplastic combined chemotherapy protocols - administration & dosage (499) 499
young adult (498) 498
peritoneal neoplasms - metabolism (480) 480
laparoscopy (475) 475
adenocarcinoma (473) 473
diagnosis, differential (471) 471
adenocarcinoma - secondary (465) 465
ovarian neoplasms - therapy (460) 460
expression (454) 454
paclitaxel - administration & dosage (443) 443
carcinoma - drug therapy (441) 441
trial (440) 440
hipec (419) 419
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9806) 9806
Japanese (568) 568
French (208) 208
German (193) 193
Italian (82) 82
Spanish (62) 62
Chinese (51) 51
Russian (46) 46
Polish (20) 20
Dutch (12) 12
Hungarian (12) 12
Romanian (12) 12
Danish (10) 10
Portuguese (9) 9
Czech (5) 5
Finnish (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Korean (3) 3
Croatian (2) 2
Swedish (2) 2
Arabic (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 20, pp. 2449 - 2456
Journal Article
Journal Article
Annals of oncology, ISSN 0923-7534, 2016, Volume 27, Issue 8, pp. 1386 - 1422
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 03/2015, Volume 22, Issue 4, pp. 1073 - 1079
Journal Article
Cancer Cell, ISSN 1535-6108, 07/2014, Volume 26, Issue 1, pp. 77 - 91
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 131, Issue 1, pp. 36 - 41
Abstract Objective We evaluated the clinical outcome and prognostic factors for post-relapse survival (PRS) in a large retrospective series of ovarian cancer... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Anatomic site of disease | Favourable prognosis | Recurrent ovarian cancer | Localized relapse | Secondary debulking surgery | SURVIVAL | METASTASIS | SECONDARY CYTOREDUCTIVE SURGERY | IDENTIFICATION | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | 2ND-LINE | THERAPY | CISPLATIN | ONCOLOGY | RECURRENT | CARCINOMA | Lymph Nodes - pathology | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Brain Neoplasms - pathology | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Brain Neoplasms - surgery | Neoplasm Recurrence, Local - pathology | Platinum Compounds - therapeutic use | Young Adult | Brain Neoplasms - secondary | Lung Neoplasms - secondary | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Retrospective Studies | Liver Neoplasms - secondary | Carcinoma - secondary | Peritoneal Neoplasms - secondary | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Neoplasm Recurrence, Local - therapy | Peritoneal Neoplasms - surgery | Neoplasms, Glandular and Epithelial - therapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Splenic Neoplasms - surgery | Splenic Neoplasms - pathology | Carcinoma, Ovarian Epithelial | Ovarian Neoplasms - therapy | Carcinoma - therapy | Aged | Neoplasm Staging | Splenic Neoplasms - secondary | Care and treatment | Cancer patients | Prognosis | Patient outcomes | Ovarian cancer | Index Medicus
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 10/2015, Volume 61, Issue 4, pp. 415 - 420
OBJECTIVES:The aim of the present study was to document the clinical presentation, diagnostic studies, and therapy of gastrointestinal infantile hemangiomas.... 
Hemangioma | Diagnostic imaging | Gastrointestinal | Bleeding | hemangioma | PROPRANOLOL | bleeding | ULCERATED HEMANGIOMAS | CUTANEOUS HEMANGIOMAS | diagnostic imaging | CHILDREN | gastrointestinal | VASCULAR ANOMALIES | NUTRITION & DIETETICS | THERAPY | MALFORMATIONS | SEGMENTAL HEMANGIOMAS | PEDIATRICS | UPDATE | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | Hemangioma - pathology | Hemangioma, Cavernous - therapy | Humans | Anemia - prevention & control | Hospitals, Pediatric | Infant | Male | Peritoneal Neoplasms - diagnosis | Gastrointestinal Neoplasms - pathology | Hemangioma - therapy | Hemangioma, Cavernous - diagnosis | Neoplasms, Second Primary - therapy | Skin Neoplasms - diagnosis | Female | Hemangioma, Cavernous - pathology | Retrospective Studies | Melena - etiology | Anemia - etiology | Infant, Newborn | Boston | Facial Neoplasms - diagnosis | Peritoneal Neoplasms - pathology | Diagnosis, Differential | Facial Neoplasms - physiopathology | Facial Neoplasms - therapy | Skin Neoplasms - therapy | Combined Modality Therapy | Mesentery | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Hemangioma - diagnosis | Skin Neoplasms - physiopathology | Neoplasms, Second Primary - diagnosis | Hemangioma - physiopathology | Gastrointestinal Hemorrhage - prevention & control | Gastrointestinal Hemorrhage - etiology | Melena - prevention & control | Hemangioma, Cavernous - physiopathology | Neoplasms, Second Primary - physiopathology | Gastrointestinal Neoplasms - physiopathology | Electronic Health Records | Neoplasms, Second Primary - pathology | Peritoneal Neoplasms - physiopathology | Peritoneal Neoplasms - therapy | Index Medicus
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 09/2019, Volume 120, Issue 4, pp. 794 - 802
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 75 - 87
Summary Background Poly(ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian carcinomas with homologous recombination deficiency. Along with BRCA1... 
Hematology, Oncology and Palliative Medicine | BRCA MUTATION | POLY(ADP-RIBOSE) POLYMERASE | RANDOMIZED PHASE-2 | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTANT-CELLS | PROSTATE-CANCER | INHIBITORS | DNA-REPAIR | NEGATIVE BREAST-CANCER | GENOMIC LOSS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer | Index Medicus
Journal Article
Journal Article
World Journal of Surgery, ISSN 0364-2313, 6/2012, Volume 36, Issue 6, pp. 1419 - 1431
Small intestinal neuroendocrine tumors (SI-NETs) are uncommon, with an annual incidence of about 1 per 100,000 individuals. The primary tumor (PT) is generally... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | LIVER METASTASES | SURVIVAL | SURGERY | INTERFERON | MANAGEMENT | NEURO ENDOCRINE TUMORS | PROGNOSTIC-FACTORS | MIDGUT CARCINOID-TUMORS | PERITONEAL CARCINOMATOSIS | COMBINATION | SURGICAL-TREATMENT | Lymph Node Excision | Multivariate Analysis | Prognosis | Follow-Up Studies | Intestine, Small - pathology | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Female | Retrospective Studies | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Neuroendocrine Tumors - pathology | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Peritoneal Neoplasms - surgery | Liver Neoplasms - surgery | Combined Modality Therapy | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Intestine, Small - surgery | Neuroendocrine Tumors - mortality | Survival Analysis | Neuroendocrine Tumors - surgery | Aged | Neuroendocrine Tumors - therapy | Laparotomy | Peritoneal Neoplasms - therapy | Liver cancer | Metastasis | Heart diseases | Health aspects | Coronary heart disease | Analysis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article